Security key
63009J107
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 46,821,220
- Total 13F shares
- 6,417,922
- Share change
- -2,865,440
- Total reported value
- $36,903,052
- Price per share
- $5.75
- Number of holders
- 9
- Value change
- -$14,323,739
- Number of buys
- 2
- Number of sells
- 4
Report period
Q3 2024
Institutions
9
Top holders
10
NBTX full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Nanobiotix S.A. SEC filings
Nanobiotix S.A. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 63009J107
Recent filing periods:
Top shareholders of NBTX - Nanobiotix S.A. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC |
13D/G
|
Invus Public Equities, L.P. |
8.9%
|
4,232,829
|
$13,545,053 | $0 | 31 Dec 2023 | |
| JOHNSON & JOHNSON |
13F
|
Company |
12%
|
5,623,816
|
$28,119,080 | — | 30 Jun 2024 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
6.1%
|
2,869,030
|
$14,345,150 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
555,066
|
$2,775,330 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.51%
|
239,008
|
$1,195,040 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,100
|
$15,500 | — | 30 Jun 2024 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
2,030
|
$10,150 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
760
|
$3,800 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
343
|
$1,715 | — | 30 Jun 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
263
|
$1,000 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
110
|
$550 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
33
|
$165 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2
|
$10 | — | 30 Jun 2024 |
Institutional Holders of Nanobiotix S.A. - Common Stock (NBTX) as of Q3 2024
As of 30 Sep 2024,
Nanobiotix S.A. - Common Stock (NBTX) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,417,922 shares.
The largest 10 holders included
JOHNSON & JOHNSON, PERCEPTIVE ADVISORS LLC, BlackRock, Inc., CITIGROUP INC, UBS Group AG, GAMMA Investing LLC, BANK OF AMERICA CORP /DE/, BARCLAYS PLC, RHUMBLINE ADVISERS, and MORGAN STANLEY.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
11
Q3 2024 holders
9
Holder diff
-2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.